- Visibility0
- Citations15
- Sentiment50
- Site quality87
- AI readiness14
AI assistants do not name Amarin in any of their 60 answers about its market, while the typical company in its sector is named in 3.3% of answers. Amarin's overall score is 29 out of 100, ranking 1,361st of 2,047 companies. Its website passes 2 out of 14 technical checks for AI tool readiness.
We asked 15 unbranded questions about the healthcare market: none named Amarin. AI assistants named it in none of 60 answers. The typical healthcare company is named in 3.3% of answers. By how often it is named, Amarin ranks 69 of 105 in its sector.
Named fewer than three times in total. Read this as a sign that AI assistants rarely bring this company up, not as an exact comparison with its rivals.
Every dot is a company in the study. Hover one to see it; click to open its report.
This companySame sectorEvery other companyNever named
Five parts, each scored out of 100.
How often AI assistants name the company
How often AI uses the company's own website as a source
How positively AI describes the company
How well built the website's own pages are
How easily AI tools can read and use the website
Visibility is calculated from the answers on this page. How the score is built.
105 companies in this sector. The line on each bar is the typical company.
How the mentions in these answers were split between this company and its rivals
Answers naming it, out of answers received
What this website publishes for an AI agent to read, use and buy from, on a scale of six levels.
- 0
- 1
- 2
- 3
- 4
- 5
Level 1: Basic web presence. Two of robots.txt, a sitemap and Link headers are in place.
- Content Signals
Show every check, for your technical teamHide the checks
- study: 92.0%robots.txtPassed
A valid robots.txt with crawl rules at the site root.
- study: 86.8%SitemapPartly met
Serve an XML sitemap and reference it from robots.txt.
- study: 0.3%Link headersNot met
Send Link headers such as rel="api-catalog" or rel="describedby" on the homepage.
- study: 5.5%DNS for AI DiscoveryNot present
Advertise agent endpoints with SVCB records under _agents.
- study: 1.9%Markdown negotiationNot met
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
- study: 25.1%llms.txtNot met
Publish an llms.txt with a short summary and the key links.
- study: 93.4%AI bot rulesPassed
Explicit robots.txt rules for AI crawlers such as GPTBot, ClaudeBot and PerplexityBot.
- study: 1.4%Content SignalsNot met
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
- study: 0.2%Web Bot AuthNot present
Only relevant if you run your own agents or crawlers: publish a signing key directory.
- study: 0.3%API CatalogNot met
List public APIs in a linkset at /.well-known/api-catalog.
- study: 11.8%OAuth discoveryNot met
Publish OpenID Connect or OAuth server metadata under /.well-known.
- study: 10.3%OAuth Protected ResourceNot met
Serve protected resource metadata at /.well-known/oauth-protected-resource.
- study: 0.0%auth.mdNot met
Publish an auth.md describing how agents sign in.
- study: 0.2%MCP Server CardCould not check
Offer an MCP server and publish its server card under /.well-known.
- study: 0.1%A2A Agent CardCould not check
Publish an agent card at /.well-known/agent-card.json.
- study: 0.2%Agent SkillsCould not check
Publish a skills index with the main tasks agents can do.
- study: 33.7%WebMCPCould not check
Register key actions such as search or cart as WebMCP tools.
- study: 0.1%ARD manifestCould not check
Publish an ai-catalog.json listing every agent interface.
Score 38 of 100 · 79% of checks could run · checked on October 5, 2026 · www.amarincorp.com · 2,047 companies scanned
2 of 14 passed. This list is for your technical team. The percentage is how many companies in the study pass each check.
These 14 checks ran during the audit and are what the AI readiness part of the overall score counts. The scan above ran later and is stricter on Link headers and Markdown, so a check can pass here and not there.
Show the 14 checksHide them
- Not metrobots.txt publishedstudy: 85.0%
- Not metXML sitemapstudy: 73.2%
- Not metHTTP Link headers (RFC 8288)study: 29.0%
- PassedMarkdown content negotiationstudy: 8.3%
- Not metllms.txt publishedstudy: 21.7%
- PassedToken budget (page weight)study: 95.2%
- Not metExplicit AI bot rulesstudy: 13.0%
- Not metAPI Catalog (.well-known/api-catalog)study: 0.2%
- Not metOAuth Authorization Server discoverystudy: 10.1%
- Not metOAuth Protected Resource discoverystudy: 9.3%
- Not metMCP Server Cardstudy: 0.0%
- Not metA2A Agent Cardstudy: 0.0%
- Not metWebMCP toolsstudy: 4.2%
- Not metAgent Skills declaredstudy: 0.0%
How many times each website was listed as a source in these answers
In the study as US-listed.
- What should I do if I'm not seeing improvements in my cholesterol levels despite medication?
- How do prescription omega-3 therapies compare to statins for cardiovascular protection?
- How do insurance plans typically cover cardiovascular medications for high-risk patients?
- Best therapies for managing cholesterol to prevent heart disease in the US
- Are there cost-effective prescription options for lowering cardiovascular disease risk in the US?
- What non-pharmaceutical interventions are effective for lowering cholesterol in high-risk patients?
- How to manage side effects of prescription cardiovascular therapies
- How can high-risk adults benefit from intensive cardiovascular risk-reduction strategies?
- When is it appropriate to add prescription omega-3 fatty acids to standard cardiovascular care?
- Is prescription cardiovascular care worth the higher cost for high-risk patients?
- Latest advancements in medical therapy for reducing the burden of cardiovascular disease
- Alternatives to prescription medications for cardiovascular risk reduction
- What are the most effective treatment options for reducing cardiovascular risk in high-risk adults?
- Do high-risk heart patients really need advanced lipid-lowering therapy, or are lifestyle changes enough?
- Differences between prescription cardiovascular medications and over-the-counter supplements
Columns, left to right: OpenAI, Claude, Perplexity, Gemini. The AI assistants often disagree. Across the study, on 40% of the questions where a company is named, only one of the four names it.